Halaven Post-Marketing Surveillance (PMS)

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Breast Cancer
Trial Locations (12)

Unknown

Busan

Chuncheongnam-do

Chungcheongbuk-do

Chungcheongnam-do

Daegu

Gwangju

Gyeonggi-do

Gyeongsanbuk-do

Gyeongsannam-do

Jeollabuk-do

Jeollanam-do

Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT02441764 - Halaven Post-Marketing Surveillance (PMS) | Biotech Hunter | Biotech Hunter